Trasylol Side Effects Kidney Failure, Heart Attack and Strokes
In a recent study, published in the May 29, 2008 New England Journal of Medicine, a Canadian government team found that Trasylol was twice as likely to cause death as similar, and almost equally effective, drugs. In fact, the study was stopped early for ethical reasons, as it was too dangerous to continue giving Trasylol to patients.
A 2006 study had already reported that the drug Trasylol, then widely used during coronary artery bypass graft (CABG) surgery to limit blood loss, had been associated with the following Trasylol side effects:
- Double the risk of kidney failure
- Increased risk of stroke
- Increased risk of encephalopathy
- Increased risk of heart attack
The FDA (Food and Drug Administration) directed Bayer, the manufacturer of Trasylol to suspend sales of the drug in the U.S. on November 5, 2007. On May 14, 2008, Bayer voluntarily began removing the last stocks of the drug from the U.S. market.
If you have had CABG, heart valve, or knee or hip replacement surgery and believe you suffered side effects, such as Trasylol kidney failure, Trasylol stroke, Trasylol encephalopathy, or Trasylol heart attack, you may be entitled to recover damages for your injury.
Check out the following articles for more information about Trasylol, filing a Trasylol lawsuit and finding a Trasylol attorney.
- Trasylol: Overview
- Trasylol: FDA Warning
- Trasylol Study, Information and Updates
- Trasylol Lawsuits and Litigation
- Trasylol Attorneys: How to Find and Hire